During this engaging discussion, Dr. Sehnert shares insights on how organizations can better align scientific innovation with the needs of patients, including:
Whether you’re involved in clinical development, operations, or strategic partnerships, this recorded session will offer practical perspectives on advancing patient-centered innovation in precision medicine.
Amy Sehnert, MD, FACC is Chief Medical Officer at Thryv Therapeutics, where she leads the development of innovative cardiovascular therapies. A physician-scientist and executive leader, she has more than 20 years of experience advancing novel medicines through clinical development, regulatory approval, and commercialization. Previously, Dr. Sehnert held senior leadership roles at Bristol Myers Squibb, leading global cardiovascular programs. She is passionate about translating scientific innovation into meaningful patient outcomes and is an active member of the Biotech CMO Sisterhood and the University of Minnesota Medical School Alumni Board.
Join the live webinar and gain insights from our learning.
“The better question is: How will India surpass China as a global pharma power?”